Mogrify and Astellas collaborate on novel gene therapy for hearing loss
Labiotech - 17-Nov-2022Breakthrough approach to regenerate new cochlear hair cells that enable hearing
Join the club for FREE to access the whole archive and other member benefits.
Innovation in ophthalmology with addition of novel gene therapy program for glaucoma
Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company. Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the Americas and around the world.
Visit website: https://www.astellas.com/eu/
Details last updated 03-Oct-2019
Breakthrough approach to regenerate new cochlear hair cells that enable hearing
mRNA technology-reset aging to extend health span and improve quality of life